Results 221 to 230 of about 349,408 (306)

Fetal Adrenal Gland Ultrasound Parameters in Pregnancies with Fetal Growth Restriction Defined by Delphi Criteria: A Prospective Single-Center Case-Control Study. [PDF]

J Clin Med
Özalp E, Akbulut ÖV, Sucu S, Kurt DS, Çelen Ş, Yücel KY.   +5 more
europepmc   +1 more source

A Ten Year Overview of Adrenal Vein Sampling in Croatia: Insights and Outcomes

Clinical Endocrinology, EarlyView.
ABSTRACT Background Adrenal vein sampling (AVS) is the gold standard for subtype differentiation in primary aldosteronism (PA), yet it remains technically demanding and resource intensive. However, data on long‐term performance, learning curves, and concordance with imaging in real‐world clinical practice are limited.
Karin Zibar Tomsic, Ana Marija Alduk, Elvira Kresic, Ivana Kraljevic, Darko Kastelan   +4 more
wiley   +1 more source

Angiomatoid fibrous histiocytoma of the adrenal gland: a clinical and pathological observation of two cases. [PDF]

World J Surg Oncol
Yang L, Xiao L, Li J, Wei K, Shi L, Chen J, Chen G.   +6 more
europepmc   +1 more source

A New Case of Lethal Congenital Contracture Syndrome Type 3 With Hyperinsulinism and Optic Atrophy

Clinical Genetics, EarlyView.
PIP5K1C‐related lethal congenital contracture syndrome with hyperinsulinism and optic atrophy. ABSTRACT Lethal congenital contracture syndrome 3 (LCCS3, MIM #611369) is a rare autosomal recessive neuromuscular disorder caused by biallelic loss‐of‐function (LOF) variants in PIP5K1C, reported in only two families to date.
Tameemi Abdalla Moady, Hadar Hulin Ma'ayan, Michal Cohen, Karin Weiss   +3 more
wiley   +1 more source

Investigation of the Relationship Between Adrenal Gland Signal Intensity and Age in Whole-body MRI/DWIBS. [PDF]

In Vivo
Mohri T, Okada Y, Uchiyama YO, Saigusa S, Fujikawa H, Sakurai H, Tanaka K, Wada S, Nishida M, Ueda H, Tsujii K, Goto T, Yasumoto K, Zenzai A, Hayashi D, Nakatani A, Kazama C, Saito K.   +17 more
europepmc   +1 more source

Glucocorticoids and HPA axis regulation in the stress–obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions

Clinical Obesity, Volume 15, Issue 2, April 2025.
Summary Chronic stress, characterized by increased long‐term exposure to the glucocorticoid hormone cortisol, is increasingly linked to obesity development. Still, various knowledge gaps persist, including on underlying pathophysiological mechanisms. The aim of the current review is to provide the latest insights on the connection between stress and ...
Robin Lengton, Myrte Schoenmakers, Brenda W. J. H. Penninx, Mariëtte R. Boon, Elisabeth F. C. van Rossum   +4 more
wiley   +1 more source

Impact of blunt adrenal gland injury (BAGI) in major trauma: a systematic review and meta-analysis. [PDF]

World J Emerg Surg
Benuzzi L, Cioffi SPB, Granieri S, Panagini G, Altomare M, Spota A, Virdis F, Bini R, Mingoli A, Chiara O, Cimbanassi S.   +10 more
europepmc   +1 more source

Therapies for Cardiovascular‐Kidney‐Liver‐Metabolic Syndrome: Reappraisal of Fibrates

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Cardiovascular disease, chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), obesity and metabolic dysfunction‐associated steatohepatitis (MASH) frequently coexist and share overlapping pathophysiology, forming the proposed cardiovascular‐kidney‐liver‐metabolic (CKLM) syndrome.
Virginia Anagnostopoulou, Christoforos K. Travlos, Lucas Lage Marinho, Thomas A. Mavrakanas, João Pedro Ferreira, Abhinav Sharma   +5 more
wiley   +1 more source

Disseminated cryptococcosis involving the adrenal gland and brain in an immunocompetent patient: A case report. [PDF]

Medicine (Baltimore)
Rao Q, Wu F, Su D, Song X, Su J, Ma L, Xu J, Fan S, Zhu J, Wen J.   +9 more
europepmc   +1 more source

A Biweekly GLP‐1R Agonist Designed With Drug‐Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim To develop a next‐generation, longer‐acting, more‐clinical‐benefits agonist to achieve sustained efficacy with improved tolerability. Methods CT130 was designed from semaglutide. Binding affinity was validated via molecular dynamics and cellular assays.
Wei Ding, Qing Liu, Qiong Luo, Xiaojun Yao, Xingxing Fan   +4 more
wiley   +1 more source